Active ingredients: normal immunoglobulin
What it is used for
CUVITRU is indicated as replacement therapy in adult and paediatric patients for, Primary immunodeficiency diseases (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
How to take it
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear and colourless to pale yellow or light brown solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems